Related Experiment Video
Updated: Jan 23, 2026

A New Murine Model of Endovascular Aortic Aneurysm Repair
Published on: July 7, 2013
Mycotic aortic aneurysm due to brucellosis
Abdullah Alhaizaey1, Mohammed Alassiri1, Musaed Alghamdi1
1Division of Vascular Surgery, Aseer Central Hospital, King Khalid University, Abha, Saudi Arabia.
Brucellosis can cause rare aortic aneurysms. Management varies, with one patient treated surgically and another conservatively with antibiotics, highlighting the need for awareness in endemic regions.
Area of Science:
- Infectious Diseases
- Vascular Surgery
- Cardiology
Background:
- Brucellosis is a zoonotic disease with systemic effects.
- Mycotic aneurysms, particularly those caused by Brucella, are infrequent and lack standardized treatment protocols.
Observation:
- Two cases of mycotic aortic aneurysm caused by Brucella are presented.
- The first case involved surgical resection of an infrarenal abdominal aortic aneurysm with long-term antibiotic therapy (doxycycline and rifampicin).
- The second case showed improvement with conservative management, including a six-month antibiotic course and ongoing monitoring.
Findings:
- Successful management of Brucella-related mycotic aortic aneurysms can be achieved through both surgical intervention and conservative antibiotic therapy.
- Individualized treatment approaches are crucial given the rarity and varied presentations of these aneurysms.
Implications:
- This study emphasizes the importance of recognizing Brucella as a potential cause of mycotic aneurysms.
- It highlights the need for tailored management strategies for arterial complications of brucellosis, especially in areas where the disease is endemic.
- Increased clinical suspicion and appropriate diagnostic workup are essential for timely intervention.
Related Concept Videos
Aneurysm I: Introduction
Aneurysm IV: Nursing Management
Aneurysm III: Interprofessional Care
Aortic Regurgitation I: Introduction
Aneurysm II: Clinical Manifestations and Diagnostic Studies
Aortic Regurgitation III: Medical Management

